Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR+32.4%
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+32.4%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
4.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025124.28%
20240.51%
2023-120.61%
2022-63.36%
2021-117.66%
202030.60%
2019-2.82%
201825.08%
2017-283.12%
2016336.81%